Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Cost Of Living
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
Give Feedback
Australia markets open in 2 hours 52 minutes
ALL ORDS
7,937.50
-0.40
(-0.01%)
AUD/USD
0.6522
+0.0022
(+0.33%)
ASX 200
7,683.00
-0.50
(-0.01%)
OIL
83.78
+0.97
(+1.17%)
GOLD
2,344.50
+6.10
(+0.26%)
Bitcoin AUD
99,565.02
+1,190.62
(+1.21%)
Cellectar Biosciences Inc (NV4.BE)
Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
2.8800
0.0000
(0.00%)
At close: 08:08PM CEST
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
28,211
28,211
19,220
17,586
10,141
Selling general and administrative
10,749
10,749
9,594
6,545
5,150
Total operating expenses
38,961
38,961
28,814
24,131
15,290
Operating income or loss
-38,961
-38,961
-28,814
-24,131
-15,290
Total other income/expenses net
530
530
-
6.634
185.28
Income before tax
-38,043
-38,043
-28,661
-24,122
-15,094
Income tax expense
-60
-60
-60
0
-
Income from continuing operations
-37,983
-37,983
-28,601
-24,122
-15,094
Net income
-37,983
-37,983
-28,601
-24,122
-15,094
Net income available to common shareholders
-37,983
-37,983
-28,601
-24,122
-15,094
Basic EPS
-3.26
-3.11
-4.05
-4.35
-7.60
Diluted EPS
-3.26
-3.11
-4.05
-4.35
-7.60
Basic average shares
10,931
12,222
7,056
5,552
1,981
Diluted average shares
10,931
12,222
7,056
5,552
1,981
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.